Computed from published fixed rules, not a model's judgement — though one input, the count of high-severity risks, comes from the AI analysis below.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
UHS delivered strong FY2025 results with revenue rising 9.7% to $17.4B and net income surging 30.4% to $1.49B, driven by improved operating leverage and margin expansion across its hospital operations.
Revenue
$17.36B
+9.71% YoY
EPS (Diluted)
$23.10
+37.34% YoY
Operating Income
$1.99B
+18.56% YoY
Source: SEC XBRL
Universal Health Services (UHS) reported FY2025 revenue of $17.36B, up 9.7% year over year. Operating margin was 11.5%, up 0.9 points from 10.6% a year earlier. Operating cash flow was $1.86B, down 9.8% year over year.
Last 4 quarters: 2 beats
| Quarter | Actual EPS (USD) | Consensus (USD) | Result |
|---|---|---|---|
| Jun 2026 | 5.98 | 6.02 | Miss -0.6% |
| Mar 2026 | 5.62 | 5.46 | Beat +2.9% |
| Dec 2025This filing | 5.88 | 5.96 | Miss -1.3% |
| Sep 2025 | 5.69 | 4.88 | Beat +16.5% |
Reported EPS of $5.88 versus the $5.96 analyst consensus — a -1.3% miss for Dec 2025.
Compiled by AI from this SEC filing
UHS grew total revenue by 9.7% year-over-year to $17.36B in FY2025, up from $15.83B in the prior year, reflecting strong patient volume growth and favorable pricing across its acute care and behavioral health segments.
Source: 10-K Income Statement, Financial Data
Operating income rose 18.6% to $1.99B, outpacing revenue growth and expanding operating margin by approximately 86 basis points to 11.5%, indicating improved cost management and operational efficiency.
Source: 10-K Income Statement, Financial Data
Net income jumped 30.4% to $1.49B, while diluted EPS surged 37.3% to $23.10 (from $16.82), with the outsized EPS gain partly attributable to share buybacks reducing the share count.
Source: 10-K Income Statement & Cash Flow, Financial Data
UHS repurchased $968M in shares during FY2025, a 44.3% increase from $671M in the prior year, meaningfully reducing the share count and boosting per-share earnings metrics.
Source: 10-K Cash Flow Statement, Financial Data
Despite strong earnings growth, operating cash flow declined 9.8% to $1.86B from $2.07B in the prior year, suggesting higher working capital consumption or timing differences in cash collections that investors should monitor.
Source: 10-K Cash Flow Statement, Financial Data
Compiled by AI from this SEC filing · 2 high, 3 medium, 0 low
Current liabilities surged 46.6% to $3.24B while current assets grew only 21.0% to $3.41B, compressing the current ratio to just 1.05x. This thin liquidity buffer leaves UHS with limited margin of safety to absorb unexpected short-term obligations or cash flow disruptions.
Source: 10-K Balance Sheet, Financial Data
Operating cash flow fell 9.8% to $1.86B even as net income rose 30.4%, creating a notable gap between reported earnings and cash generation. This divergence may reflect rising accounts receivable, deferred revenue timing, or accrual-based income items that have not yet converted to cash.
Source: 10-K Cash Flow Statement, Financial Data
Long-term debt increased 5.5% to $4.75B in FY2025, representing a significant leverage position relative to the company's equity base. Combined with aggressive share buybacks consuming nearly $1B in cash, the balance sheet leaves limited flexibility for unexpected capital needs.
Source: 10-K Balance Sheet & Cash Flow, Financial Data
Investing cash outflows increased 17.5% to -$1.07B, reflecting higher capital expenditure needs likely tied to facility upgrades, technology investments, or acquisitions. Sustained capex growth could pressure free cash flow if operating cash flow does not recover.
Source: 10-K Cash Flow Statement, Financial Data
As a large hospital system, UHS is heavily dependent on Medicare and Medicaid reimbursement rates, which are subject to federal and state policy changes. Any reduction in government reimbursement rates or unfavorable regulatory changes could materially impact revenue and profitability.
Source: 10-K Risk Factors (inferred from business model), Financial Data
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue $B | 17.36 $B | 15.83 $B | +9.71% |
Operating Income $B | 1.99 $B | 1.68 $B | +18.56% |
Net Income $B | 1.49 $B | 1.14 $B | +30.36% |
EPS (Basic) $ | 23.42 $ | 17.16 $ | +36.48% |
EPS (Diluted) $ | 23.10 $ | 16.82 $ | +37.34% |
Answers draw on this SEC filing and the data on this page
UHS grew second-quarter revenue 8.3% but saw operating margin shrink as costs rose, and it warned that Medicaid-related legislative changes could erode future profits, while preparing to acquire Talkspace for $835 million.
UHS delivered strong Q1 FY2026 results with revenue rising 9.6% YoY to $4.50B and net income growing 10.1% to $348.7M, driven by solid operational performance across its hospital segments.
Other companies in Health Care Facilities